Incannex Healthcare Inc.
IXHL
$0.2177
$0.01577.77%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 36.67% | 106.50% | 105.69% | 89.19% | 68.11% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 58.40% | 99.54% | 34.89% | 33.10% | 24.26% |
Operating Income | -57.70% | -98.80% | -34.81% | -36.20% | -30.81% |
Income Before Tax | -73.40% | -103.03% | 40.93% | 46.93% | 54.90% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -73.61% | -103.29% | 40.83% | 46.93% | 54.90% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -73.61% | -103.29% | 40.83% | 46.93% | 54.90% |
EBIT | -57.70% | -98.80% | -34.81% | -36.20% | -30.81% |
EBITDA | -56.13% | -98.12% | -34.48% | -70.41% | -138.91% |
EPS Basic | -62.15% | -93.11% | 44.77% | 43.51% | 45.66% |
Normalized Basic EPS | -61.93% | -92.88% | -30.39% | -65.04% | -113.95% |
EPS Diluted | -62.15% | -93.11% | 44.77% | 43.51% | 45.66% |
Normalized Diluted EPS | -61.93% | -92.88% | -30.39% | -65.04% | -113.95% |
Average Basic Shares Outstanding | 7.38% | 5.41% | 4.21% | -82.10% | -90.19% |
Average Diluted Shares Outstanding | 7.38% | 5.41% | 4.21% | -82.10% | -90.19% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |